Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Steven Bradley to Myocardial Infarction

This is a "connection" page, showing publications Steven Bradley has written about Myocardial Infarction.

 
Connection Strength
 
 
 
3.726
 
  1. Sidebottom AC, Miedema MD, Benson G, Vacquier M, VanWormer JJ, Sillah A, Lindberg R, Boucher JL, Bradley SM. The impact of a population-based prevention program on cardiovascular events: Findings from the heart of new Ulm project. Am Heart J. 2021 09; 239:38-51.
    View in: PubMed
    Score: 0.566
  2. Bradley SM. Use of Mobile Health and Patient-Generated Data-Making Health Care Better by Making Health Care Different. JAMA Netw Open. 2020 04 01; 3(4):e202971.
    View in: PubMed
    Score: 0.525
  3. Bradley SM, Hess E, Winchester DE, Sussman JB, Aggarwal V, Maddox TM, Barón AE, Rumsfeld JS, Ho PM. Stress Testing After Percutaneous Coronary Intervention in the Veterans Affairs HealthCare System: Insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2015 Sep; 8(5):486-92.
    View in: PubMed
    Score: 0.379
  4. Bradley SM, Rao SV, Curtis JP, Parzynski CS, Messenger JC, Daugherty SL, Rumsfeld JS, Gurm HS. Change in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2014 Jul; 7(4):550-9.
    View in: PubMed
    Score: 0.351
  5. Bradley SM, Carey EP, Michael Ho P. US growth in PCI care--less than ideal, but is the ideal less? J Am Heart Assoc. 2013 Nov 19; 2(6):e000552.
    View in: PubMed
    Score: 0.338
  6. Maynard C, Bradley SM. Acute coronary syndromes: Bypassing the emergency department to treat STEMI. Nat Rev Cardiol. 2013 Sep; 10(9):491-2.
    View in: PubMed
    Score: 0.331
  7. Marquis-Gravel G, Roe MT, Robertson HR, Harrington RA, Pencina MJ, Berdan LG, Hammill BG, Faulkner M, Muñoz D, Fonarow GC, Nallamothu BK, Fintel DJ, Ford DE, Zhou L, Daugherty SE, Nauman E, Kraschnewski J, Ahmad FS, Benziger CP, Haynes K, Merritt JG, Metkus T, Kripalani S, Gupta K, Shah RC, McClay JC, Re RN, Geary C, Lampert BC, Bradley SM, Jain SK, Seifein H, Whittle J, Roger VL, Effron MB, Alvarado G, Goldberg YH, VanWormer JL, Girotra S, Farrehi P, McTigue KM, Rothman R, Hernandez AF, Jones WS. Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. JAMA Cardiol. 2020 05 01; 5(5):598-607.
    View in: PubMed
    Score: 0.132
  8. Kini V, Peterson PN, Spertus JA, Kennedy KF, Arnold SV, Wasfy JH, Curtis JP, Bradley SM, Amin AP, Ho PM, Masoudi FA. Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2018 10; 11(10):e004788.
    View in: PubMed
    Score: 0.118
  9. Wasfy JH, Kennedy KF, Masoudi FA, Ferris TG, Arnold SV, Kini V, Peterson P, Curtis JP, Amin AP, Bradley SM, French WJ, Messenger J, Ho PM, Spertus JA. Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004635.
    View in: PubMed
    Score: 0.118
  10. Gunja A, Stanislawski MA, Barón AE, Maddox TM, Bradley SM, Vidovich MI. The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program. Clin Cardiol. 2018 Jun; 41(6):809-816.
    View in: PubMed
    Score: 0.116
  11. Raghavan S, Liu WG, Michael Ho P, Plomondon ME, Barón AE, Caplan L, Joynt Maddox KE, Magid D, Saxon DR, Voils CI, Bradley SM, Maddox TM. Coronary artery disease severity modifies associations between glycemic control and both mortality and myocardial infarction. J Diabetes Complications. 2018 05; 32(5):480-487.
    View in: PubMed
    Score: 0.113
  12. Aggarwal V, Armstrong EJ, Liu W, Maddox TM, Ho PM, Carey E, Wang T, Sherwood M, Tsai TT, Rumsfeld JS, Bradley SM. Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program. Clin Cardiol. 2016 Oct; 39(10):578-584.
    View in: PubMed
    Score: 0.103
  13. Hegeman TW, Glorioso TJ, Hess E, Barón AE, Ho PM, Maddox TM, Bradley SM, Burke RE. Facility-Level Percutaneous Coronary Intervention Readmission Rates Are Not Associated With Facility-Level Mortality: Insights From the VA Clinical Assessment, Reporting, and Tracking (CART) Program. J Am Heart Assoc. 2016 09 14; 5(9).
    View in: PubMed
    Score: 0.103
  14. Maddox TM, Stanislawski MA, Grunwald GK, Bradley SM, Ho PM, Tsai TT, Patel MR, Sandhu A, Valle J, Magid DJ, Leon B, Bhatt DL, Fihn SD, Rumsfeld JS. Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA. 2014 Nov 05; 312(17):1754-63.
    View in: PubMed
    Score: 0.090
  15. Maddox TM, Stanislawski MA, O'Donnell C, Plomondon ME, Bradley SM, Ho PM, Tsai TT, Shroff AR, Speiser B, Jesse RJ, Rumsfeld JS. Patient access and 1-year outcomes of percutaneous coronary intervention facilities with and without on-site cardiothoracic surgery: insights from the Veterans Affairs (VA) Clinical Assessment, Reporting, and Tracking (CART) program. Circulation. 2014 Oct 14; 130(16):1383-91.
    View in: PubMed
    Score: 0.089
  16. Shore S, Carey EP, Turakhia MP, Jackevicius CA, Cunningham F, Pilote L, Bradley SM, Maddox TM, Grunwald GK, Barón AE, Rumsfeld JS, Varosy PD, Schneider PM, Marzec LN, Ho PM. Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. Am Heart J. 2014 Jun; 167(6):810-7.
    View in: PubMed
    Score: 0.087
  17. Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013 Nov 06; 310(17):1829-36.
    View in: PubMed
    Score: 0.084
  18. Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM. Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004623.
    View in: PubMed
    Score: 0.029
  19. Kobayashi T, Glorioso TJ, Armstrong EJ, Maddox TM, Plomondon ME, Grunwald GK, Bradley SM, Tsai TT, Waldo SW, Rao SV, Banerjee S, Nallamothu BK, Bhatt DL, Rene AG, Wilensky RL, Groeneveld PW, Giri J. Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals. JAMA Cardiol. 2017 09 01; 2(9):967-975.
    View in: PubMed
    Score: 0.027
  20. Bittl JA, Baber U, Bradley SM, Wijeysundera DN. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 09 06; 68(10):1116-39.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)